David Leverenz
LightNews LightNews
banner
davidleverenz.bsky.social
David Leverenz
@davidleverenz.bsky.social
44 followers 30 following 1 posts
Rheumatology fellowship PD at #DukeRheum. Crazy about rheumatology. Creator of @rheummadness.bsky.social. Looking forward to seeing what #rheumsky is like. Views mine.

Learn more about RheumMadness: https://sites.duke.edu/rheummadness/
Posts Replies Media Videos
Reposted by David Leverenz
rheumarhyme.bsky.social
For me it's more like DAZ is Hector's Shield. #RheumMadness #GreekMythology

sites.duke.edu/rheummadness...
CD40L Inhibitor in Sjogren's - RheumMadness
Team: CD40L Inhibitor in Sjögren’s, aka the “Sjögren Horse” Base article: St Clair EW, Baer AN, Ng WF, et al. CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, pla...
sites.duke.edu
February 3, 2025 at 11:28 AM
Reposted by David Leverenz
rheumarhyme.bsky.social
ListeningRheum👂notes: #RheumMadness

🤔CD40L pathway has potential in SLE 🦋 #Dapirolizumab-pegol

#ACR24 abs: acrabstracts.org/abstract/dap...

📻https://rheummadness.buzzsprout.com/1465681/episodes/16400130-5-2-t-d-up-t-cells?t=0
5.2 T'd Up T-Cells - RheumMadness Podcast
In this episode, we dive in to the T'd Up T-cells region of RheumMadness 2025: the Innovation Invitational.  This is the first of a two-part conversation with the authors of the scouting reports ...
rheummadness.buzzsprout.com
February 1, 2025 at 6:37 AM
Reposted by David Leverenz
rheummadness.bsky.social
Plus a new #RheumMadness podcast episode!

www.buzzsprout.com/1465681/epis...
5.4 Cytokine Crushers - RheumMadness Podcast
In this episode, we are joined by Michael Macklin, MD, PharmD, Assistant Professor of Medicine at the University of Chicago, to discuss the teams in the Cytokine Crushers region of RheumMadness 2025, ...
www.buzzsprout.com
January 22, 2025 at 6:00 PM
davidleverenz.bsky.social
Diamond dogs assemble!
January 4, 2025 at 4:32 AM